Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000805230 | SCV000945178 | uncertain significance | Cerebral creatine deficiency syndrome | 2022-07-19 | criteria provided, single submitter | clinical testing | This sequence change replaces phenylalanine, which is neutral and non-polar, with cysteine, which is neutral and slightly polar, at codon 157 of the GAMT protein (p.Phe157Cys). This variant is present in population databases (rs751570656, gnomAD 0.007%). This variant has not been reported in the literature in individuals affected with GAMT-related conditions. ClinVar contains an entry for this variant (Variation ID: 650133). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Natera, |
RCV001275203 | SCV001460080 | uncertain significance | Deficiency of guanidinoacetate methyltransferase | 2020-01-24 | no assertion criteria provided | clinical testing |